PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

2 in 1: Multi-tasking protein provides new approaches for anti-tuberculosis drugs

2011-02-16
(Press-News.org) VIDEO: Three snapshots of the 3-D structure of Mycobacterium tuberculosis' enzyme PriA are combined in this video to show the changes the enzyme is capable of undergoing.
Click here for more information.

In a paper published today in PNAS, scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, reveal new insights into the workings of enzymes from a group of bacteria including Mycobacterium tuberculosis, the bacterium that causes tuberculosis. The new findings present possible new opportunities for developing organism-specific drugs, which target the pathogen but leave other microorganisms, which are beneficial to us, untouched.

Tuberculosis remains one of the largest threats to human health worldwide, and one of the most frequent causes of death in HIV patients. With the increasing emergence of strains of Mycobacterium tuberculosis that are hyper-resistant to drugs, it becomes ever more urgent that novel treatments be developed, and the search for novel strategies for drug development is an important step in this process.

In the current study, Matthias Wilmanns and his group at EMBL identified a multi-tasking enzyme from Mycobacterium tuberculosis that catalyses reactions on two different molecules, or substrates. In most organisms, cells need two specific enzymes, known as HisA and TrpF, in order to produce two essential amino acids – histidine and tryptophan. However, in Mycobacterium tuberculosis, the encoding gene for TrpF is missing, and the two reactions are instead catalysed by a single enzyme, which is able to recognize and bind to two different substrates. This enzyme is known as PriA.

Using the Mycobacterium tuberculosis version of the PriA enzyme as a model, the researchers were able to unravel the hitherto unknown mechanism of bi-substrate specific binding observed in this group of bacteria.

"When we solved the three-dimensional structure of PriA, we found that it has the unique ability to form two different substrate-specific active sites," Wilmanns says: "it can form a reaction-specific active site, or undergo what we call 'substrate-induced metamorphosis' to form a different active site."

To further verify these observations, Wilmanns and colleagues screened 20,000 small molecule compounds, and identified a handful which inhibited both PriA-catalysed reactions but had no effect on TrpF activity.

"We believe that this ability for bi-substrate catalysis in Mycobacterium tuberculosis could be a new opportunity for future drug development," Wilmanns concludes: "This organism-specific reaction process could be exploited, since only the pathogen but none of the other bacteria living in or on humans, many of which are important for our well being, would be targeted."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Unique new probe of proton spin structure at RHIC

2011-02-16
UPTON, NY - Scientists hoping to unravel the mystery of proton spin at the Relativistic Heavy Ion Collider (RHIC, http://www.bnl.gov/rhic/), a 2.4-mile-circumference particle accelerator at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, have a new tool at their disposal - the first to directly explore how quarks of different types, or "flavors," contribute to the overall spin of the proton. The technique, described in papers just published by RHIC's STAR and PHENIX collaborations in Physical Review Letters, relies on the measurement of particles called ...

Good diets fight bad Alzheimer's genes

Good diets fight bad Alzheimers genes
2011-02-16
Scientists today agree that there are five molecules that are known to affect or cause Alzheimer's disease, which plagues an estimated five million Americans. The potency of these molecules is linked to environmental factors such as diet and lifestyle. Prof. Daniel Michaelson of Tel Aviv University's Department of Neurobiology at the George S. Wise Faculty of Life Sciences has illuminating news about one of these five molecules — APOE, created by the apolipoprotein E. gene found in all of our bodies. Prof. Michaelson says APOE comes in two forms, a "good" APOE gene ...

How do women fend off domestic violence?

How do women fend off domestic violence?
2011-02-16
This release is available in French. Montreal, February 15, 2011 — For many women in violent relationships, leaving is not an option. Yet a woman's arsenal of defenses for resisting violence critically depends on her position within the family and community, according to new research from Concordia University published in the journal Review of Radical Political Economics. "Women's resistance is often conceptualized only as exit, which is problematic," says study author Stephanie Paterson, a professor in the Concordia University Department of Political Science and ...

Using chlorhexidine gluconate baths to reduce hospital-acquired infections

Using chlorhexidine gluconate baths to reduce hospital-acquired infections
2011-02-16
CHG cloths more effective in reducing risk for acquiring HAIs Study shows 64 percent decreased risk of infection from MRSA or VRE May be beneficial for both ICU and general medical unit patients PROVIDENCE, R.I. – A new study from Rhode Island Hospital has found a reduced risk of hospital-acquired infections (HAI) when using two percent chlorhexidine gluconate (CHG) cloths for daily bathing instead of soap and water. The study found a 64 percent decrease in the risk of acquiring an infection from either methicillin-resistant Staphylococcus aureus (MRSA) or Vancomycin-resistant ...

'Healthy' patients at high risk of cardiac death identified

2011-02-16
The way the heart responds to an early beat is predictive of cardiac death, especially for people with no conventional markers of cardiovascular disease, according to new research from Washington University School of Medicine in St. Louis. The conventional risk factors, such as high cholesterol, smoking, diabetes and high blood pressure, account for many but not all deaths from cardiovascular causes. As a result, doctors are always searching for better ways to identify patients at risk of cardiac death. The new research indicates that an abnormal response to an early ...

UF leads world in reconfigurable supercomputing

2011-02-16
GAINESVILLE, Fla. — University of Florida researchers say their supercomputer, named Novo-G, is the world's fastest reconfigurable supercomputer and is able to perform some important science applications faster than the Chinese supercomputer touted as the world's most powerful. In November, the TOP500 list of the world's most powerful supercomputers, for the first time ever, named the Chinese Tianhe-1A system at the National Computer Center in Tainjin, China as No. 1. In his state of the union speech, President Barack Obama noted, "Just recently, China became home ...

EARTH: Oil and water help US win World War II

2011-02-16
Alexandria, VA – The U.S. had two key strategic advantages over the Axis in World War II: oil and water. Although other factors played major roles in the U.S. and its allies winning the war, these two natural resources played a much larger role than recognized. World War II was the first highly mechanized war. In the March feature "How Oil and Water Helped the U.S. Win World War II," EARTH magazine explores how the abundance of domestic US oil and water in the South and Pacific Northwest drove not only tanks and planes, but also industrial production and technological ...

Study compares balanced propofol sedation with conventional sedation for therapeutic GI endoscopic procedures

2011-02-16
OAK BROOK, Ill. – Feb. 15, 2011 – Researchers from Korea report that, compared with conventional sedation, balanced propofol sedation (BPS) using propofol in combination with midazolam and meperidine, provided higher health care provider satisfaction, better patient cooperation, and similar adverse event profiles in patients undergoing therapeutic endoscopic procedures. This is the first prospective study of BPS in direct comparison with conventional sedation. The researchers note that this study provides further evidence to support the adoption of endoscopist-directed ...

FASEB praises President Obama for increasing funding for research in his FY 2012 budget

2011-02-16
Bethesda, MD - William T. Talman, MD, President of the Federation of American Societies for Experimental Biology (FASEB), praised President Barack Obama for his continuing support for science and engineering. "The President recognizes that our future depends on research," Talman stated. In a letter to President Obama, Talman noted that his "support for this critical investment—even during a time of unprecedented budgetary constraints—will help to improve the lives of millions of people." In his FY 2012 Budget, President Obama proposed a $745 million increase over the ...

A device enables the remote explosion of improvised land-mines

2011-02-16
Composed of diverse elements, mostly of plastic, with little metal used, improvised explosive devices are very difficult to detect. In cooperation with two colombian universities, scientists at EPFL's Electromagnetic Compatibility Laboratory have found a solution. They have developed a device enabling the remote explosion of these mines, by using the energy from their electromagnetic impulses. This type of mine is often used by guerillas or terrorist groups in conflict zones, and is present in many regions of the world, such as Colombia, Iraq and Afghanistan. They kill ...

LAST 30 PRESS RELEASES:

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

Slow editing of protein blueprints leads to cell death

Industrial air pollution triggers ice formation in clouds, reducing cloud cover and boosting snowfall

Emerging alternatives to reduce animal testing show promise

Presenting Evo – a model for decoding and designing genetic sequences

Global plastic waste set to double by 2050, but new study offers blueprint for significant reductions

Industrial snow: Factories trigger local snowfall by freezing clouds

Backyard birds learn from their new neighbors when moving house

New study in Science finds that just four global policies could eliminate more than 90% of plastic waste and 30% of linked carbon emissions by 2050

Breakthrough in capturing 'hot' CO2 from industrial exhaust

New discovery enables gene therapy for muscular dystrophies, other disorders

[Press-News.org] 2 in 1: Multi-tasking protein provides new approaches for anti-tuberculosis drugs